About this FactMed analysis covering adverse side effect reports of ACTIT patients who developed DYSURIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking ACTIT reported DYSURIA to the FDA. A total of 67 ACTIT drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACTIT and DYSURIA. In doing so, we compare ACTIT with other drugs that cause DYSURIA, to help you evaluate whether or not ACTIT causes DYSURIA. Likewise, this page shows the most highly-reported side effects of ACTIT, so you can see if DYSURIA ranks among ACTIT's most well-known side effects.
Summary Statistics
Reports of ACTIT causing DYSURIA: 2
Reports of any side effect of ACTIT : 67
Percentage of ACTIT patients where DYSURIA is a reported side effect: 2.9851%

FDA reports of any drug causing DYSURIA : 12485
Average percentage for all medicated patients where DYSURIA is reported as a complication: 0.0782%

Physician opinion on ACTIT as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACTIT:
PYREXIA ( 5 patients )
INFUSION ( 4 patients )
DECREASED APPETITE ( 3 patients )
FLUID REPLACEMENT ( 2 patients )
ASTHMA ( 1 patients )
DEHYDRATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with DYSURIA:

FOSAMAX (1472 patients)
ASPIRIN (1174 patients)
VIOXX (973 patients)
ZOMETA (927 patients)
SEROQUEL (653 patients)
LIPITOR (630 patients)
SPIRIVA (584 patients)
LASIX (534 patients)
HUMIRA (496 patients)
IMMUCYST (485 patients)
NEURONTIN (485 patients)
PREDNISONE (479 patients)
LISINOPRIL (479 patients)
AREDIA (469 patients)
FLOMAX (469 patients)
AMBIEN (468 patients)
NEXIUM (465 patients)
LYRICA (448 patients)
XANAX (429 patients)
CELEBREX (428 patients)
COUMADIN (422 patients)
PAXIL (416 patients)
SYNTHROID (405 patients)
PRILOSEC (397 patients)
AVONEX (390 patients)
OXYCONTIN (385 patients)
PERCOCET (381 patients)
TYSABRI (377 patients)
CYMBALTA (372 patients)
ATENOLOL (354 patients)
FOLIC ACID (351 patients)
VICODIN (348 patients)
SIMVASTATIN (344 patients)
HYDROCHLOROTHIAZIDE (340 patients)
ALBUTEROL (336 patients)
FUROSEMIDE (332 patients)
PREVACID (331 patients)
ATIVAN (331 patients)
VITAMIN D (328 patients)
OMEPRAZOLE (323 patients)
LORAZEPAM (322 patients)
LEVAQUIN (315 patients)
DIGOXIN (304 patients)
HEPARIN SODIUM INJECTION (304 patients)
CRESTOR (301 patients)
ACCUTANE (297 patients)
DEXAMETHASONE (291 patients)
PROTONIX (289 patients)
ZOCOR (287 patients)
TOPROL-XL (286 patients)
ENBREL (271 patients)
METHOTREXATE (270 patients)
NORVASC (263 patients)
LEXAPRO (262 patients)
GABAPENTIN (262 patients)
STRATTERA (262 patients)
ZOLOFT (255 patients)
DIOVAN (251 patients)
OXYCODONE HCL (242 patients)
ALLOPURINOL (241 patients)
RISPERDAL (241 patients)
ADVAIR DISKUS 100/50 (241 patients)
IBUPROFEN (237 patients)
PROZAC (237 patients)
ALPRAZOLAM (231 patients)
POTASSIUM CHLORIDE (231 patients)
ACETAMINOPHEN (229 patients)
PLAVIX (228 patients)
DURAGESIC-100 (226 patients)
FORTEO (225 patients)
METFORMIN HCL (221 patients)
METOPROLOL TARTRATE (218 patients)
CALCIUM (215 patients)
ZOFRAN (214 patients)
LEVOTHYROXINE SODIUM (214 patients)
AVODART (212 patients)
KLONOPIN (211 patients)
SANDOSTATIN LAR (211 patients)
VALIUM (209 patients)
LORTAB (206 patients)
PREMARIN (202 patients)
FLEXERIL (200 patients)
DECADRON (200 patients)
EFFEXOR (195 patients)
CELEXA (184 patients)
WARFARIN SODIUM (183 patients)
ZYPREXA (183 patients)
RADIATION THERAPY (182 patients)
PREDNISONE TAB (181 patients)
ZETIA (180 patients)
ZANTAC (179 patients)
ALENDRONATE SODIUM (177 patients)
ALLEGRA (170 patients)
TRAZODONE HCL (169 patients)
ZITHROMAX (169 patients)
COMPAZINE (169 patients)
ZYRTEC (168 patients)
EXJADE (167 patients)
CHANTIX (166 patients)
VALTREX (166 patients)
REGLAN (166 patients)
TRAMADOL HCL (165 patients)
AMOXICILLIN (164 patients)
VITAMIN E (163 patients)
CIPROFLOXACIN (162 patients)
MULTI-VITAMINS (162 patients)
REVLIMID (161 patients)
CLONAZEPAM (160 patients)
LANTUS (159 patients)
DILAUDID (159 patients)
PREDNISOLONE (159 patients)
FENTANYL (158 patients)
CHEMOTHERAPEUTICS NOS (156 patients)
WELLBUTRIN (154 patients)
TYLENOL (CAPLET) (152 patients)
COLACE (152 patients)
MORPHINE (152 patients)
FEMARA (151 patients)
SINGULAIR (150 patients)
DETROL LA (149 patients)
TAXOTERE (149 patients)
PROCRIT (146 patients)
DOXYCYCLINE (145 patients)
CIPRO (144 patients)
VIAGRA (144 patients)
MULTI-VITAMIN (143 patients)
ACIPHEX (143 patients)
GLUCOPHAGE (142 patients)
COREG (141 patients)
REBIF (141 patients)
CLARITIN (137 patients)
METOPROLOL (136 patients)
PEPCID (136 patients)
REMICADE (136 patients)
BACLOFEN (135 patients)
THALIDOMIDE (134 patients)
PROMETHAZINE (133 patients)
ASCORBIC ACID (132 patients)
DIFLUCAN (131 patients)
LOVENOX (130 patients)
TYLENOL (129 patients)
BACTRIM (128 patients)
AMITRIPTYLINE HCL (128 patients)
ULTRAM (127 patients)
BYETTA (127 patients)
EFFEXOR XR (127 patients)
FOSAMAX PLUS D (127 patients)
NEORAL (126 patients)
VITAMIN B-12 (126 patients)
MOTRIN (125 patients)
AMLODIPINE (124 patients)
DEPAKOTE (124 patients)
ACYCLOVIR (124 patients)
ELAVIL (124 patients)
ACTOS (123 patients)
NITROGLYCERIN (123 patients)
TOVIAZ (121 patients)
KEFLEX (120 patients)
HYDROCODONE BITARTRATE (120 patients)
MORPHINE SULFATE (120 patients)
DIAZEPAM (119 patients)
LOPRESSOR (119 patients)
RANITIDINE (119 patients)
BENADRYL (118 patients)
HYDROCODONE (118 patients)
CYCLOPHOSPHAMIDE (118 patients)
ENALAPRIL MALEATE (116 patients)
GLIPIZIDE (115 patients)
OXYCODONE HCL AND ACETAMINOPHEN (115 patients)
METOCLOPRAMIDE (114 patients)
TAMOXIFEN CITRATE (114 patients)
COZAAR (113 patients)
TAMSULOSIN HCL (112 patients)
INSULIN (111 patients)
GLYBURIDE (111 patients)
ALEVE (110 patients)
CLINDAMYCIN (110 patients)
TOPAMAX (110 patients)
RIBAVIRIN (108 patients)
AVELOX (107 patients)
VELCADE (106 patients)
ABILIFY (106 patients)
CEPHALEXIN (105 patients)
CASODEX (103 patients)
MIRALAX (103 patients)
PANTOPRAZOLE (102 patients)
CARBOPLATIN (102 patients)
MOBIC (102 patients)
MIRENA (102 patients)
ACTONEL (102 patients)
ROCEPHIN (101 patients)
FLUCONAZOLE (101 patients)
PHENERGAN (100 patients)
TEGRETOL (100 patients)
COMBIVENT (100 patients)
FLONASE (99 patients)
MIRTAZAPINE (99 patients)
FASLODEX (99 patients)
FISH OIL (99 patients)
XELODA (99 patients)
PEGASYS (99 patients)
LANSOPRAZOLE (99 patients)
NAPROXEN (98 patients)
LAMICTAL (98 patients)
ARANESP (98 patients)
CYCLOSPORINE (98 patients)
CALCIUM CARBONATE (96 patients)
PROSCAR (96 patients)
PERIDEX (94 patients)
GLEEVEC (94 patients)
Most common side effects for patients taking ACTIT:
BLOOD POTASSIUM DECREASED (12 patients)
DIZZINESS POSTURAL (12 patients)
MULTIPLE SCLEROSIS RELAPSE (12 patients)
PALPITATIONS (12 patients)
LIVER DISORDER (7 patients)
NAUSEA (7 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (6 patients)
PYREXIA (6 patients)
ALANINE AMINOTRANSFERASE INCREASED (5 patients)
DYSPNOEA (5 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (5 patients)
HYPERTHERMIA (5 patients)
BLOOD PRESSURE DECREASED (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
HEPATIC FUNCTION ABNORMAL (4 patients)
ILEUS (4 patients)
PNEUMONIA (4 patients)
PNEUMONIA ASPIRATION (4 patients)
STEVENS-JOHNSON SYNDROME (4 patients)
WHITE BLOOD CELL COUNT INCREASED (4 patients)
ANOREXIA NERVOSA (3 patients)
DECREASED APPETITE (3 patients)
DEPRESSION (3 patients)
DIARRHOEA (3 patients)
DRUG WITHDRAWAL SYNDROME (3 patients)
DYSPHORIA (3 patients)
GASTROINTESTINAL ULCER (3 patients)
HAEMATOCRIT DECREASED (3 patients)
MALAISE (3 patients)
PARKINSONISM (3 patients)
RENAL FAILURE (3 patients)
SHOCK HAEMORRHAGIC (3 patients)
SOMNOLENCE (3 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (3 patients)
VOMITING (3 patients)
ANORECTAL OPERATION (2 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (2 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (2 patients)
BLOOD UREA INCREASED (2 patients)
BRONCHIAL HAEMORRHAGE (2 patients)
CARDIAC FAILURE (2 patients)
COLD SWEAT (2 patients)
COUGH (2 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (2 patients)
DRUG ERUPTION (2 patients)
DYSKINESIA (2 patients)
DYSURIA (2 patients)
FIBRINOLYSIS INCREASED (2 patients)
GENERALISED ERYTHEMA (2 patients)
HAEMODIALYSIS (2 patients)
HAEMORRHAGE SUBCUTANEOUS (2 patients)
HEPARIN-INDUCED THROMBOCYTOPENIA (2 patients)
HEPATITIS ACUTE (2 patients)
HEPATITIS FULMINANT (2 patients)
MELAENA (2 patients)
PAIN (2 patients)
PLATELET COUNT DECREASED (2 patients)
PLATELET COUNT INCREASED (2 patients)
PNEUMONIA BACTERIAL (2 patients)
PRODUCTIVE COUGH (2 patients)
PROTEIN TOTAL DECREASED (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE ACUTE (2 patients)
RESPIRATORY ARREST (2 patients)
THROMBOCYTOPENIA (2 patients)
URINARY TRACT INFECTION (2 patients)
WHEEZING (2 patients)
WHITE BLOOD CELL COUNT DECREASED (2 patients)
ABNORMAL BEHAVIOUR (1 patients)
ANOREXIA (1 patients)
BACK PAIN (1 patients)
BLOOD GLUCOSE INCREASED (1 patients)
BLOOD PRESSURE INCREASED (1 patients)
BLOOD URINE PRESENT (1 patients)
BRADYCARDIA (1 patients)
C-REACTIVE PROTEIN INCREASED (1 patients)
CACHEXIA (1 patients)
CAESAREAN SECTION (1 patients)
CHILLS (1 patients)
CHOLANGITIS SCLEROSING (1 patients)
COAGULATION TEST ABNORMAL (1 patients)
COAGULOPATHY (1 patients)
COMA (1 patients)
CONJUNCTIVAL HYPERAEMIA (1 patients)
CONSTIPATION (1 patients)
CONVULSION (1 patients)
DEATH (1 patients)
DIZZINESS (1 patients)
DRUG EXPOSURE DURING PREGNANCY (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG INTERACTION (1 patients)
FALL (1 patients)
FEELING ABNORMAL (1 patients)
FOETAL GROWTH RETARDATION (1 patients)
FUNGAL TEST POSITIVE (1 patients)
GASTROINTESTINAL DISORDER (1 patients)
GASTROINTESTINAL HAEMORRHAGE (1 patients)
HEADACHE (1 patients)
HEPATIC NEOPLASM MALIGNANT (1 patients)
HYPERCALCAEMIA (1 patients)
HYPERKALAEMIA (1 patients)
HYPOMANIA (1 patients)
INJURY ASPHYXIATION (1 patients)
INTERSTITIAL LUNG DISEASE (1 patients)
IRRITABILITY (1 patients)
LIVER FUNCTION TEST ABNORMAL (1 patients)
LYMPHADENOPATHY (1 patients)
LYMPHOCYTE STIMULATION TEST POSITIVE (1 patients)
MALNUTRITION (1 patients)
MUSCLE RIGIDITY (1 patients)
MYDRIASIS (1 patients)
OCULOMUCOCUTANEOUS SYNDROME (1 patients)
ORGANISING PNEUMONIA (1 patients)
PLEURAL EFFUSION (1 patients)
POST PROCEDURAL COMPLICATION (1 patients)
PRE-ECLAMPSIA (1 patients)
PROCTALGIA (1 patients)
PULMONARY TUBERCULOSIS (1 patients)
RASH GENERALISED (1 patients)
RED BLOOD CELL ANISOCYTES PRESENT (1 patients)
RENAL CELL CARCINOMA (1 patients)
RESPIRATORY DISORDER (1 patients)
SEPSIS (1 patients)
SPEECH DISORDER (1 patients)
STUPOR (1 patients)
SUDDEN DEATH (1 patients)
TACHYCARDIA (1 patients)
WHITE BLOOD CELLS URINE POSITIVE (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ACTIT


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about DYSURIA and ACTIT, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACTIT, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACTIT. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACTIT experts. If you are a healthcare provider experienced in prescribing ACTIT, please register here.
giCould not connect: